Contact this trialFirst, we need to learn more about you.
mTOR Inhibitor
Everolimus for Tracheal Stenosis
Recruiting1 awardPhase < 1
Baltimore, Maryland
This trial is testing the drug everolimus to see if it can reduce the number of surgeries needed for patients with idiopathic Subglottic Stenosis (iSGS), a condition where scar tissue blocks the airway. Everolimus helps by calming the immune system and reducing scar tissue formation. If successful, this could lead to everolimus becoming an approved treatment for iSGS.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service